Increasing Orthopedic Diseases Have Put Platelet Rich Plasma Market At A Market Value Of 230 Million And Is Expected To Grow At A CAGR Of 13.8%.

Increasing Orthopedic Diseases Have Put Platelet Rich Plasma Market At A Market Value Of 230 Million And Is Expected To Grow At A CAGR Of 13.8%.

ID: 7937 | October 2018 | Region: Global


Platelet Rich Plasma Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the BCG Vaccine Market is estimated to be USD 230 million in 2017 and predicted to rise to USD 450 million by 2022 with a CAGR of 13.8%.

Platelet-rich Plasma is purified plasma protein with red blood cells removed out of it and used for its greater concentration of growth factors. Platelet-rich plasma can regenerate ligaments and tendon fibres. PRP treatments are tissue healing techniques with wide range of applications. Rise in Cosmetic surgeries and orthopaedic diseases are the key growth factors of this market. In some cases PRP therapy can prevent the need for surgery which is helping the market grow rapidly. The lack of any possible side effects for this process is making the demand for PRP much higher.

The market is segmented by Application and by Product. By Application it is divided into Orthopedics, Cosmetic surgery, Ophthalmic surgery, Neurosurgery. By product it can be further segmented into Pure, Leukocyte-rich, Leukocyte-rich Fibrin. The market is dominated by pure PRP segmented because of less inflammatory responses and effective results in bone regeneration. Leukocyte-rich PRP is expected to rise with a high growth rate owing to its efficiency in healing soft tissue. Among applications the market is dominated by Orthopedics segment which includes treating diseases like Rotator cuff tears, Achilles tendinopathy, Osteoarthritis. Applications in Cosmetology are also predicted to increase in market value with rising demand for Cosmetic surgery techniques. PRP therapy is the go-to method for soft tissue healing and thus is projected to grow steadily in market value in upcoming years.  

By geography the market is segmented into Latin America, Asia Pacific, Europe, North America, and Middle East and Africa. Greater developments in plasma therapy and increasing number of orthopedic diseases have made North America occupy a major share of the market . Asia-Pacific is expected to witness steady rise in market value with increasing awareness towards Cosmetic surgery and medical tourism.

Some of the key manufacturers of PRP market include DR. PRP AMERICA, LLC, Glofinn Oy, Zimmer Biomet, DePuy Synthes, Emcyte Corporation,Terumo BCT, Anthrex Inc, T-Biotechnology, Stryker.

 Browse through the full report at https://marketdataforecast.com/market-reports/platelet-rich-plasma-market-7928/

and checkout our recent reports in the Healthcare ategory at https://marketdataforecast.com/category/healthcare-1/

For more insights and up-to-date industry news don’t forget subscribing to our newsletters.

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.